University of Aveiro at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

University of Aveiro brings 2 presentations to ESGCT 2026 in Hamburg. Its work looks at the regulatory side of advanced therapy development. Both studies draw on a biomaterial and cell combination for spinal cord injury, one on structured risk management in preclinical work and one on how such a product gets classified.

OrganizationESGCT 2026 Attendance
University of Aveiro
Aveiro, Portugal
Poster
Wed Oct 28
1:30pm–3:30pm
A Structured Risk‑Management Approach in Preclinical ATMP Development: Insights from a Spinal Cord Injury Biomaterial Case Study
Other
Clinical trials and translation
Poster
Thu Oct 29
2:00pm–4:00pm
ATMP Classification challenges illustrated through a Spinal Cord Injury biomaterial–cell combination case
Regulatory (poster only)

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Aveiro

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction